feed,title,long_url,short_url
🔐MarketWatch,Keros Therapeutics started at buy with $65 stock price target at BofA Securities,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=KROS&siteid=rss,https://da.gd/oSAhPn
